Domain I of ß2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/0961203319851571
PubMed Identifier: 31126213
Publication URI: http://europepmc.org/abstract/MED/31126213
Type: Journal Article/Review
Volume: 28
Parent Publication: Lupus
Issue: 7
ISSN: 0961-2033